CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
3 hedge funds and large institutions have $8.83K invested in Loncar China BioPharma ETF in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Jane Street
New York
|
-$560K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.73K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BBPWM
1
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $5.49K | – | – | – |
|
2
Morgan Stanley
New York
| $3.35K | – | – | – |
|
|
3
Jane Street
New York
| – | -$560K | -29,839 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$4.73K | -252 | Closed |
|